Is QSAR relevant to drug discovery?

IDrugs

Volumn 11, Issue 12, 2008, Pages 894-899

  Doweyko, A M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Correlation; Predictivity; QSAR

Indexed keywords

CHEMICAL STRUCTURE; CORRELATION ANALYSIS; DRUG DESIGN; DRUG RESEARCH; EXPERIMENTAL MODEL; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; THEORETICAL MODEL;

COMPUTATIONAL BIOLOGY; DRUG DESIGN; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RESEARCH; SUBJECT HEADINGS;

EID: 57349132537     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Doweyko A: Three-dimensional quantitative structure-activity relationship: The state of the art. In: Comprehensive Medicinal Chemistry II. Taylor JB, Triggle DJ (Eds), Elsevier, New York, NY, USA (2007):575-595.
2. Kubinyi H: From narcosis to hyperspace: The history of QSAR. Quant Struct-Activity Relat (2002) 21(4):348-356.
3. Maggiora GM: On outliers and activity cliffs - why QSAR often disappoints. J Chem Inf Model (2006) 46(4):1535.
4. Johnson SR: The trouble with QSAR (or how I learned to stop worrying and embrace fallacy). J Chem Inf Model (2008) 48(1):25-26.
5. Kubinyi H: QSAR and 3D QSAR in drug design. Part I: methodology. Drug Discov Today (1997) 2(11):457-467.
6. Dearden JC, Cronin MTD: Quantitative structure-activity relationships (QSAR) in drug design. In: Smith and Williams' Introduction to the Principles of Drug Design and Action. Smith HJ (Ed), CRC Press LLC, Boca Raton, FL, USA (2006):185-209.
7. Cronin MTD, Schultz TW: Pitfalls in QSAR. J Mol Struct Theochem (2003) 622(1):39-51.
8. Stigler S: Correlation and causation. Perspect Biol Med (2005) 48(Suppl 1):s88-s94.
9. Walker JD, Jaworska J, Comber MHI, Schultz TW, Dearden JC: Guidelines for developing and using quantitative structure-activity relationships. Environ Toxicol Chem (2003) 22(8):1653-1665.
10. Dunn WJ 3rd: Quantitative structure-activity relationships. In: Drug Discovery Technologies. Clark CR, Moos WH (Eds), Ellis Horwood Ltd, Chichester, UK (1990):22-43.